Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's ... - BNET PDF Print
BNETA subgroup analysis of anemia patients not yet on dialysis showed more cardiovascular side effects with Hematide. In one trial, patients on Hematide needed

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.